跳至主要内容
临床试验/IRCT20230218057444N1
IRCT20230218057444N1尚未招募3 期

Evaluating the prescription of short-term and medium-term effects of coenzyme Q?? on the inflammatory system and renal function in patients undergoing open heart surgery

Ghoum University of Medical Sciences0 个研究点目标入组 41 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
41

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • The inclusion criteria for all patients over 18 years of age, suffering from coronary artery disease undergoing CABG surgery, is the glomerular filtration rate (GFR) greater than 45ml/min.

排除标准

  • current coenzyme Q10 therapy, which has high-risk features that warrant urgent coronary angiography (within 4 hours); the existence of sensitivity to CoQ10, people with kidney failure who need dialysis; Exposure to contrast media in the past 7 days, left ventricular ejection fraction (LVEF) <30, administration of N-acetylcysteine within 48 hours postoperatively, and refusal of consent.

研究者

发起方
Ghoum University of Medical Sciences

相似试验